A17V (p.Ala17Val) variant of CALR (Calreticulin)

A17V (p.Ala17Val) in CALR (Calreticulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes population frequency data and structural context.

A17V (p.Ala17Val) variant details